PIK3CA mutations define favorable prognostic biomarkers in operable breast cancer: a systematic review and meta-analysis
Yi-Rong Liu,* Yi-Zhou Jiang,* Wen-Jia Zuo, Ke-Da Yu, Zhi-Ming ShaoDepartment of Breast Surgery, Cancer Center and Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, *These authors contributed equally to this publication Background: Mutati...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-04-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/pik3ca-mutations-define-favorable-prognostic-biomarkers-in-operable-br-a16430 |